OSUR News and Press, OraSure Technologies Inc. From 03/22/22

Board Continues Search for Permanent CEO Evaluation of Strategic Alternatives Ongoing BETHLEHEM, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and micro...

Gainers: BioNTech (BNTX) +72%. Trip.com Group Limited (TCOM) +25%. StoneCo  (STNE) +21%. OraSure Technologies (OSUR) +6%. Brookline Bancorp (BRKL) +5%. Losers: Arcturus Therapeutics Holdings  (ARCT) -12%. Embark Technology (EMBK) -9%. CymaBay Therapeutics&#x...

Gainers: OraSure Technologies (NASDAQ:OSUR) +5%, Iovance Biotherapeutics (NASDAQ:IOVA) +4%, Marqeta (NASDAQ:MQ) +3%, Chimerix (NASDAQ:CMRX) +3%, Ribbon Communications (NASDAQ:RBBN) +3%. Losers: Incannex Healthcare (NASDAQ:IXHL) -10%, CarParts.com (NASDAQ:PRTS) -5%, Eargo (NASDAQ:EAR) -5%...

At first glance, shares of Meridian Bioscience look quite affordable, especially considering recent growth. But investors need to pay attention to the likely temporary improvement caused by the COVID-19 pandemic. Adjusting for this, the company looks much more expensive than it do...

OraSure Technologies has done well to grow its revenue over the past few years, benefiting in part from the COVID-19 pandemic. This, combined with management's plans to look at ways to grow the company more rapidly, have allowed shares to trade at lofty multiples. Part of the disc...

The following slide deck was published by OraSure Technologies, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: OraSure Technologies, Inc. 2021 Q4 - Results - Earnings Call Presentation

OraSure Technologies, Inc. (OSUR) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants Stephen Tang - President and Chief Executive Officer Scott Gleason - Interim Chief Financial Officer, Senior Vice President Corporate Communications and Investor Relations Lisa...

OraSure Technologies press release (NASDAQ:OSUR): Q4 GAAP EPS of -$0.14 beats by $0.02. Revenue of $63.57M (+1.1% Y/Y) beats by $3.58M. For further details see: OraSure Technologies GAAP EPS of -$0.14 beats by $0.02, revenue of $63.57M beats by $3.58M

Total 2021 revenue of $233.7 million, up 36% year-over year InteliSwab ® receives emergency use authorization expansion and demonstrates accurate detection of Omicron variant InteliSwab ® revenue of $14.7 million in Q4, up 92% sequential...

BETHLEHEM, Pa., Feb. 16, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 fourth quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 23, 2022. ...